A study of skin features, laboratory features and response to treatment with various anti-fungal drugs in patients with recurrent superficial fungal infections
Not Applicable
- Conditions
- Health Condition 1: B359- Dermatophytosis, unspecified
- Registration Number
- CTRI/2020/04/024864
- Lead Sponsor
- Maharajahs institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Clinically diagnosed cases of recurrent dermatophytoses infection with at least one episode of relapse with 4Â weeks of completing the recommended duration of anti fungal therapy.
2. Both sexes between the age groups 18 - 70 yrs.
Exclusion Criteria
1. Infants, patients below 18 years and above 70 years
2. Immunocompromised patients (HIV).
3. Pregnant and lactating females.
4. Patients receiving multiple drugs (glucocorticoids, statins, etc.) for other medical conditions.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method